课题基金 / 基金详情

Core--Clinical

Core--Clinical
核心--临床
批准号：
7354824
负责人：
Elizabeth Goldmuntz
金额：
$51.87万
依托单位：
CHILDREN'S HOSP OF PHILADELPHIA
依托单位国家：
美国
项目类别：
财政年份：
2007
资助国家：
美国
项目状态：
已结题
起止时间：
2007-02-01 至 2009-01-31
来源：
https://reporter.nih.gov/project-details/7354824
关键词：
AgeAnatomyBiologicalBloodCardiacCardiovascular systemClinicalClinical DataClinical ResearchComplement component C1sConditionCross-Sectional StudiesDataDefectDiseaseElectrocardiogramEthnic OriginEtiologyExercise stress testGenderGene MutationGenotypeGoalsGuidelinesHealthInvestigationMolecularMolecular AnalysisNumbersOperative Surgical ProceduresOutcomePatientsPersonal SatisfactionPhenotypePopulationPopulation StudyProtocols documentationQuestionnairesRaceRecordsRecruitment ActivityResearch DesignResearch Ethics CommitteesRosaSafetySamplingServicesStudy SubjectTestingTimeTranslatingVisitXenograft procedureagedbaseprobandprogramsresearch clinical testing

项目摘要

项目成果

Elizabeth Goldmuntz的其他基金

相似基金

相关文献

中文摘要
翻译
临床核心的总体目标是确定合格的研究受试者，协调他们参与研究方案，并获得研究所需的所有相关样本和数据。对于本核心研究和项目而言，最重要的是我们纳入了所有合格受试者，不分人种、性别、年龄或种族，并且我们确保他们在实施每项方案期间的安全和健康。所有研究将在获得IRB批准后并根据IRB指南进行。
英文摘要
The overall goal of the Clinical Core is to ascertain eligible study subjects, coordinate their participation in the study protocols, and acquire all relevant samples and data required for the investigations. It is of utmost importance to this Core and program that we include all eligible subjects regardless of race, gender, age or ethnicity, and that we assure their safety and well-being during the conduct of each protocol. All studies will be performed with IRB approval and according to IRB guidelines.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 2: Genetic Mechanisms of Non-syndromic Congenital Cardiac Defects
Genomewide Association Study of Conotruncal Heart Disease
Genomewide Association Study of Conotruncal Heart Disease
The Genetic Basis of Conotruncal Defects
  • 批准号：
    8298979
  • 项目类别：
  • 资助金额：
    $89.62万
  • 财政年份：
    2009
  • 负责人：
    Elizabeth Goldmuntz
  • 依托单位：
    CHILDREN'S HOSP OF PHILADELPHIA
海外基金